PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-6.26%
Negative net income growth while MRVL stands at 39.60%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
0.95%
Some D&A expansion while MRVL is negative at -12.08%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-21.50%
Negative yoy deferred tax while MRVL stands at 27.27%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
8.15%
Less SBC growth vs. MRVL's 16.85%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-72.18%
Both reduce yoy usage, with MRVL at -156.16%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-362.93%
AR is negative yoy while MRVL is 152.56%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
208.95%
Some inventory rise while MRVL is negative at -1291.11%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-227.74%
Both negative yoy AP, with MRVL at -97.00%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
59.55%
Some yoy usage while MRVL is negative at -162.25%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
296.91%
Some yoy increase while MRVL is negative at -616.73%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-36.25%
Both yoy CFO lines are negative, with MRVL at -33.25%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
22.50%
CapEx growth well above MRVL's 29.37%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
31.89%
Purchases well above MRVL's 15.40%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-5.50%
We reduce yoy sales while MRVL is 4.27%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-101.20%
We reduce yoy other investing while MRVL is 84.03%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
80.94%
Lower net investing outflow yoy vs. MRVL's 178.71%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
-0.71%
We cut debt repayment yoy while MRVL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Similar buyback growth to MRVL's 97.38%. Walter Schloss sees parallel capital return priorities or a stable free cash flow for both.